Welcome to the Definitive Platform for Advancing TIL Therapy Drug Development
With TIL therapies rapidly expanding beyond melanoma and a new generation of engineered, persistent, and precisely characterized TILs reaching patients worldwide, the 7th TIL Therapies Summit is your golden opportunity to reconnect with peers, gain exclusive insights you won’t find anywhere else, and discover how leading organizations are evolving in this dynamic field.
Whether you're preparing for your first clinical trial, seeking innovative strategies to optimize TIL manufacturing, or navigating the real-world operational challenges of rolling out these therapies at scale, this summit is your one-stop shop for everything TIL.
View The Full Event Guide To:
- Meet the 30+ expert speakers
- View full session details
- Explore registration options
Highlights of the 7th TIL Therapies Summit Include:
Gain exclusive clinical insights
from biotech frontrunners KSQ Therapeutics and Obsidian Therapeutics, as they reveal how their next-generation TIL therapies are expanding patient access through multicenter trials.
Walk away with real-world perspectives
from both sides of the treatment journey in a compelling panel led by Dr. Roda Amaria from MD Anderson Cancer Center, featuring clinicians and actual TIL patients sharing firsthand experiences.
Streamline your manufacturing strategy
with proven innovations in closed systems, faster turnaround times, and reduced reliance on IL-2 for expansion, enabling safer, more scalable, and patient-friendly TIL production.
Unlock the next wave of TIL innovation
by learning how leading R&D teams are engineering therapies to overcome the toughest challenges in persistence, specificity, and potency within the tumor microenvironment.
Accelerate your global clinical strategy
with regulatory insights from experts who’ve successfully navigated approvals with the FDA, EMA, Health Canada, and China’s NMPA, giving you a clear roadmap for international expansion.
Who Will You Meet?
Connect with top TIL stakeholders, pioneers, and wavemakers who share a focus on exploring and pushing for cutting edge TIL advancements.
* Statistics Taken from 6th TIL Therapies Summit 2024